Future Pharmaceutical Manufacturing

Date: 18 MAY 2017 08:30-17:00
Location: ALK Abelló, Bøge Allé 1, 2970 Hørsholm, Denmark

Event Venue Photo]

Continuous manufacturing, continuous process verification and ongoing process verifications are part of the new pharma reality. They are part of the EU GMP Annex 15 regulations for Qualification and Validation and part of the FDA Process Validation Guidance. They are becoming a reality. Some of the most advanced pharmaceutical companies have implemented these new techniques. They will present their practical experiences at this conference, which provides both best practice sharing and a view into the pharma factories of the future, both from the industry and the regulatory perspective.

Register Now Button

Charles Cooney, PhD photoKeynote speaker at this conference will be Charles Cooney, PhD, Professor of Chemical and Biochemical Engineering, Massachusetts Institute of technology, Boston, US Emeritus in the Department of Chemical Engineering and was the founding Faculty Director of the Deshpande Center for Technological Inovation. He serves as a consultant to a number of biotech and pharmaceutical companies, sits on the Board of Directors of Mitra Biotech, GreenLight Bioscience, Axcella Health, Boyd Technologies, Levitronix Technologies, LayerBio and Innovent Biologics and he chaired the FDA Advisory Committee for Pharmaceutical Science from 2004-2006.

Program for the Conference

08.00 Start registration, coffee, visit table top exhibition
09.00 Welcome
Gert Mølgaard, Moelgaard Consulting
09.05 To be continuous or Not to be continuous – that is the question!
Charles Cooney, Professor, Massachusetts Institute of technology, Boston, US
10.00 Requirements of Annex 15, CPV and general GMP updates
Inger Jönebring, Owner and Senior GMP Consultant at medIQ Consulting AB
10.45 Coffee break & visit table top exhibition
11.00 Quality Aspects in Continuous Manufacturing
Dr. Eric J.M. Meier, Head QA Continuous Manufacturing, Novartis Pharma 
11.45 From Batch to Continuous - in theory and in practice.
Andreas Blomberg and Pirjo Tajarobi, Pharmaceutical Tech. & Dev., AstraZeneca Gothenburg
12.30 Lunch & visit table top exhibition
13.30 Continuous Manufacturing from a Regulatory Standpoint
Øyvind Holte, Researcher, Lekemiddelverket, Norway
14.15 End-to-End Integrated Continuous Manufacture of Monoclonal Antibodies.
Massimo Morbedelli, PhD, Professor, ETH, Switzerland
15.00 Coffee & visit table top exhibition
15.15 Continuous Manufacturing and CPV: Practical experiences from implementation
Speaker TBD, H. Lundbeck
16.00 Continuously Process Verfication at ALK – Practical Experiences
Linda Pihl and Marianne Havregaard, Senior Chemist, Production Support, ALK
16.45 Discussion and adjourn

Vendor table top exhibition during the whole conference.

Download the conference program ( 2 MB). 


Burkert Logo          PEC Logo                ALK Abellò  logo